Physician profile
Nathan Cockerill
NPI 1427548767
$741.16
in general payments reported to CMS, 2019-2025
13 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.76 · 2020: $38.96 · 2022: $164 · 2023: $15.11 · 2024: $148 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $294.03 | 2025 | Recell, Cohealyx, Permeaderm |
| Allergan, INC. | $114.38 | 2022 | |
| Shionogi INC | $101.95 | 2024 | Fetroja |
| Ethicon US, LLC | $50.02 | 2022 | |
| Acell, INC. | $38.96 | 2020 | |
| Smith+Nephew, INC. | $24.60 | 2025 | Biobrane |
| Tela Bio, INC. | $23.76 | 2019 | |
| Medline Industries Lp | $21.53 | 2025 | |
| Integra Lifesciences Corporation | $16.26 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Teleflex LLC | $15.28 | 2024 | Quikclot |
| Abbvie INC. | $15.11 | 2023 | Alloderm |
| Solventum Corporation | $14.48 | 2024 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Advanced Oxygen Therapy INC. | $10.80 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Cockerill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.